written by reader The Alzheimer’s Association estimates that, “caring for individuals with Alzheimer’s will cost American society $20 trillion.”

By Britt, May 15, 2021

“One small biotech holds the key to a revolution in treating this dreaded disease.
Jeff Bezos, Goldman Sachs & a Big Pharma giant have invested billions into this unknown biotech.”
I own LLY and BIIB because hey have, it seems, drugs that may have some effect on dementia.
The newsletter is only $19.00, but I just want to find better informed types who are looking in the drug/biotech space who might have ideas about this “touted” company and any others that have a chance to slow down Alzheimers and dementia. I’m dealing with it in my family and I expect that it touches almost all of our lives.



This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.



This site uses Akismet to reduce spam. Learn how your comment data is processed.

Inline Feedbacks
View all comments